Overexpression of the insulin‐like growth factor I receptor in human colon carcinomas
Abstract
BACKGROUND: High concentrations of insulin‐like growth factor (IGF)‐I and IGF‐II have been demonstrated in human colonic adenocarcinomas and exert mitogenic effects through paracrine/autocrine interactions with the IGF‐I receptor (IGF‐IR). However, definitive studies of IGF‐IR expression in these tissues have not been performed.METHODS: To study changes in the levels of the IGF‐IR in colorectal carcinoma, we analyzed the expression of IGF‐IR in 40 paired samples of normal and carcinomatous colonic tissue by quantitative reverse‐transcription–polymerase chain reaction (RT‐PCR), immunohistochemistry, and ligand binding.RESULTS: As measured by RT‐PCR, the IGF‐IR mRNA ratio in paired tumor and adjacent normal mucosa was higher than 2.0 in 32 of 40 (80%) samples. The overall mean IGF‐IR mRNA level was five‐fold higher in tumor versus adjacent normal mucosa (P < 0.0001). Overexpression of IGF‐IR in colon carcinomas was confirmed at the protein level by immunohistochemistry and receptor‐binding studies. Colon carcinoma cells exhibited a positive staining for IGF‐IR in 91% of all tumors (30 of 33) whereas the adjacent normal colonic epithelial cells showed only a very faint or no significant IGF‐IR immunoreactivity. Radioligand assays and Scatchard analysis in both tissue types revealed a single class of high‐affinity IGF‐IR–binding sites with a similar dissociation constant (Kd; 0.14 ± 0.02 nmol/L, n = 18). However, specific 125IGF‐I–binding and receptor concentrations were elevated in tumor membranes compared with normal mucosa (33.6 ± 5.6 vs. 22.7 ± 3.4 fmol/mg protein, P < 0.05). IGF‐I affinity crosslinking and sodium dodecyl sulfate–polyacrylamide gel electrophoresis displayed specific bands corresponding to the size of the normal α‐subunit of the IGF‐IR that were more intense in carcinomatous samples. IGF‐II mRNA levels were significantly elevated in colorectal carcinomas (P < 0.0001). The IGF‐II mRNA ratio in tumor versus normal tissue was elevated more than twofold in 28 of 40 paired samples and a positive correlation was observed between the overexpression of IGF‐II and IGF‐IR in the tumors.CONCLUSIONS: Our results demonstrate that, in addition to IGF‐II, a strong overexpression of IGF‐IR is found in the majority of colorectal carcinomas, supporting the hypothesis of an important role of the IGF system in the pathogenesis of colorectal carcinoma. Cancer 2002;95:2086–95. © 2002 American Cancer Society.DOI 10.1002/cncr.10945Keywords
This publication has 43 references indexed in Scilit:
- The growth hormone–insulin-like growth factor-I axis and colorectal cancerTrends in Molecular Medicine, 2001
- The contradictions of the insulin-like growth factor 1 receptorOncogene, 2000
- Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesisJournal of Cellular Physiology, 2000
- A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among menGrowth Hormone & IGF Research, 2000
- Differential activation of IGF-II promoters P3 and P4 in Caco-2 cells during growth and differentiationGastroenterology, 1998
- Insulin-like Growth Factors and CancerAnnals of Internal Medicine, 1995
- Insulinlike growth factors and binding proteins in colon cancerGastroenterology, 1993
- Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor αBritish Journal of Cancer, 1992
- Tumor IGF-II content in a patient with a colon adenocarcinoma correlates with abnormal expression of the geneInternational Journal of Cancer, 1991
- Abnormal expression and structural modification of the insulin‐like growth‐factor‐ii gene in human colorectal tumorsInternational Journal of Cancer, 1990